Multiplexed Diagnostic Market, by Product Type (Reagents & Consumables and Instruments), by Application (Disease Diagnostics, Molecular Diagnostics, and Drug Development), by End User (Hospitals, Clinical Laboratories, Academic & Research Institutes, and

Multiplexed Diagnostic Market, by Product Type (Reagents & Consumables and Instruments), by Application (Disease Diagnostics, Molecular Diagnostics, and Drug Development), by End User (Hospitals, Clinical Laboratories, Academic & Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The multiplexed diagnostic assay is used to identify multiple analytes in a single run cycle. Multiplex assay is used in the detection of defects such as mutation in functional biomolecules (DNA, mRNA, and protein) with the help of DNA microarray, multiplex PCR, and next-generation sequencing. In multiplexed diagnostic market, multiplexed diagnostic assay is executed in research & diagnostic laboratories, hospitals, and drug development. Moreover, this multiplexed diagnostic tool is also used in the diagnosis of various diseases, infections, drug screening, and biomarkers.
Market Dynamics
The multiplexed diagnostic market is gaining significant traction due to rising prevalence of autoimmune diseases. For instance, according to the Centers for Disease Control and Prevention (CDC), the prevalence of arthritis from 2013 to 2015 was 54 million in the U.S. adults (22.7%) and by 2040, it is expected to reach 78 million (26%) in the U.S. adults of age 18 years or above. The data represent high prevalence of autoimmune diseases, indicating the need of advance diagnostic measures, which is expected to boost growth of the multiplexed diagnostic market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the global multiplexed diagnostic market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global multiplexed diagnostic market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Luminex Corporation, Thermo Fisher, Illumine Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Abbott Laboratories, Siemens Healthineers, Agilent technologies, BioMerieux SA, and F.Hoffmann-La Roche Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, product type up-gradation, market expansion, and marketing tactics
The global multiplexed diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiplexed diagnostic market
Detailed Segmentation:
Global Multiplexed Diagnostic Market, By Product Type:
Reagents & Consumables
Instruments
Global Multiplexed Diagnostic Market, By Application:
Disease Diagnostics
Molecular Diagnostics
Drug Development
Global Multiplexed Diagnostic Market, By End User:
Hospitals
Clinical Laboratories
Academic & Research Institutes
Others
Global Multiplexed Diagnostic Market, By Region:
North America
By Product Type:
Reagents & Consumables
Instruments
By Application:
Disease Diagnostics
Molecular Diagnostics
Drug Development
By End User:
Hospitals
Clinical Laboratories
Academic & Research Institutes
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Reagents & Consumables
Instruments
By Application:
Disease Diagnostics
Molecular Diagnostics
Drug Development
By End User:
Hospitals
Clinical Laboratories
Academic & Research Institutes
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Reagents & Consumables
Instruments
By Application:
Disease Diagnostics
Molecular Diagnostics
Drug Development
By End User:
Hospitals
Clinical Laboratories
Academic & Research Institutes
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Reagents & Consumables
Instruments
By Application:
Disease Diagnostics
Molecular Diagnostics
Drug Development
By End User:
Hospitals
Clinical Laboratories
Academic & Research Institutes
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Reagents & Consumables
Instruments
By Application:
Disease Diagnostics
Molecular Diagnostics
Drug Development
By End User:
Hospitals
Clinical Laboratories
Academic & Research Institutes
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Reagents & Consumables
Instruments
By Application:
Disease Diagnostics
Molecular Diagnostics
Drug Development
By End User:
Hospitals
Clinical Laboratories
Academic & Research Institutes
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Luminex Corporation *
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Thermo Fisher
Illumine Inc.
Bio-Rad Laboratories, Inc.
Qiagen N.V.
Abbott Laboratories
Siemens Healthineers
Agilent technologies
BioMerieux SA
Hoffmann-La Roche Ltd.
“*” marked represents similar segmentation in other categories in the respective section.